Ulrich Schraermeyer

Dr. Ulrich Schraermeyer


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Experimental Eye Research
Verified
Journal Article
Closed access
ABAntje Biesemeier
Antje Biesemeier
EYEfdal Yoeruek
Efdal Yoeruek
OEOliver Eibl
Oliver Eibl
USUlrich Schraermeyer
Ulrich Schraermeyer

31 July 2011 in Experimental Eye Research
Verified
Journal Article
Closed access
ABAntje Biesemeier
Antje Biesemeier
USUlrich Schraermeyer
Ulrich Schraermeyer
OEOliver Eibl
Oliver Eibl

1 August 2006 in Experimental Eye Research
Verified
Journal Article
Closed access
USUlrich Schraermeyer
Ulrich Schraermeyer
JKJürgen Kopitz
Jürgen Kopitz
SPSwaantje Peters
Swaantje Peters
SHSigrid Henke-Fahle
Sigrid Henke-Fahle
PBPetra Blitgen-Heinecke
Petra Blitgen-Heinecke
KBKarl-Ulrich Bartz-Schmidt
Karl-Ulrich Bartz-Schmidt

12 March 2018 in PeerJ
Verified
Journal Article
Open access
PDF file
ATAlexander V. Tschulakow
Alexander V. Tschulakow
TOTheo Oltrup
Theo Oltrup
TBThomas Bende
Thomas Bende
SSSebastian Schmelzle
Sebastian Schmelzle
USUlrich Schraermeyer
Ulrich Schraermeyer
Objective: In the foveola of the eye, photoreceptors and Müller cells with a unique morphology have been described, but little is known about their 3D structure and orientation. Considering that there is an angle-dependent change in the foveolar photoreceptor response for the same light beam, known as the Stiles Crawford Effect of the first kind (SCE I), which is still not fully understood, a detailed analysis of the anatomy of the foveolar cells might help to clarify this phenomenon. Methods: Serial semithin and ultrathin sections, and focused ion beam (FIB) tomography were prepared from 32 foveolae from monkeys (Macaca fascicularis) and humans. Foveolae were also analyzed under the electron microscope. Serial sections and FIB analysis were then used to construct 3D models of central Müller and photoreceptor cells. In addition, we measured the transmission of collimated light under the light microscope at different angles after it had passed through human foveae from flat mounted isolated retinae. Results: In monkeys, outer segments of central foveolar cones are twice as long as those from parafoveal cones and do not run completely parallel to the incident light. Unique Müller cells are present in the central foveolae (area of 200 µm in diameter) of humans and monkeys. Light entering the fovea center, which is composed only of cones and Müller cells, at an angle of 0° causes a very bright spot after passing through this area. However, when the angle of the light beam is changed to 10°, less light is measured after transpasssing through the retina, the foveolar center becomes darker and the SCE-like phenomenon is directly visible. Measurements of the intensities of light transmission through the central foveola for the incident angles 0 and 10° resemble the relative luminance efficiency for narrow light bundles as a function of the location where the beam enters the pupil as reported by Stiles and Crawford. The effect persisted after carefully brushing away the outer segments. Conclusion: We show that unique cones and Müller cells with light fibre-like properties are present in the center of the fovea. These unique Müller cells cause an angle dependent, SCE-like drop in the intensity of light guided through the foveola. Outer segments from the foveolar cones of monkeys are not straight.

1 January 2008 in Retina
Verified
Journal Article
Closed access
PHPeter Heiduschka
Peter Heiduschka
SJSylvie Julien-Schraermeyer
Sylvie Julien-Schraermeyer
SHSabine Hofmeister
Sabine Hofmeister
KBKarl Ulrich Bartz-Schmidt
Karl Ulrich Bartz-Schmidt
USUlrich Schraermeyer
Ulrich Schraermeyer
Purpose: Scavenging of VEGF by specific antibodies is a promising way to treat ocular conditions connected with neovascularization. Intravitreal injections of Avastin (bevacizumab) are performed frequently as a treatment of such conditions. In this study, the authors examine whether the retinal function in wild-type mice is affected by an intravitreal injection of Avastin. Methods: Electroretinography was performed in four different experimental groups of wild-type C57BL/6 mice before treatment and 1, 4, 12, and 25 days afterwards. The first group was injected intravitreally with BSS, the second one received injections of a vehicle solution, and the third group was injected with the commercial Avastin solution. In a fourth group, sham surgery was performed. Immunohistochemistry was performed in some eyes to evaluate penetration of the bevacizumab molecule through the retina. Results: In all four groups, a similar behavior of the ERG parameters could be detected. One day after the injections, the amplitudes showed a clear decrease. Later on, they recovered gradually. No difference could be seen between eyes injected with Avastin or vehicle solution. Bevacizumab immunoreactivity was already present in the whole retina half an hour after the intravitreal injection and was not detectable 25 days later. Moreover, binding of bevacizumab to endogenous mouse VEGF could be shown. Conclusions: Based on the electroretinographic findings, the authors conclude that bevacizumab does not have any toxic effects on the mouse retina and its function. The bevacizumab molecule penetrates the retina quickly. Therefore, it can act safely and very quickly, also in deeper retinal layers after its injection.

22 May 2012 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
USUlrich Schraermeyer
Ulrich Schraermeyer
SJSylvie Julien
Sylvie Julien